Immunobiology of HPV Infection

Archives of Medical Research

Volumn 40, Issue 6, 2009, Pages 443-448

  Garcia Chacon, Rodolfo ^a   Velasco Ramirez, Sandra Fabiola ^b   Flores Romo, Leopoldo ^a   Daneri Navarro, Adrián ^b  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CANCER RISK; CELLULAR IMMUNITY; DENDRITIC CELL; DISEASE COURSE; FEMALE GENITAL SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; INNATE IMMUNITY; MICROFLORA; NATURAL KILLER CELL; PERSISTENT VIRUS INFECTION; REVIEW; T LYMPHOCYTE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; WART VIRUS;

ADAPTIVE IMMUNITY; B-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; GENITALIA, FEMALE; HUMANS; IMMUNITY, HUMORAL; KILLER CELLS, NATURAL; PAPILLOMAVIRIDAE; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS; UTERINE CERVICAL NEOPLASMS;

EID: 70350100523     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.05.003     Document Type: Review

References (40)

1. Ll Q.-M., Alcaïs A., Abel L., et al. Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat Immunol 8 (2007) 1165-1171
2. Quayle A.J., Poter E.M., Nussbaum A.A., et al. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 152 (1998) 1247-1258
3. Sharif K., and Olufowobi O. The structure, chemistry and physics of human cervical mucosa. In: Jordan J., Singer A., Jones III H.W., and Shafi M.I. (Eds). The Cervix. 2nd ed (2006), Blackwell Publishing, Oxford UK 157-168
4. Nikolaitchouk N., Andersch B., Falsen E., et al. The lower genial tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH). APMIS 116 (2008) 263-277
5. Mazmanian S.K., Round J.L., and Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453 (2008) 620-625
6. Ley R.E., Lozupone C.A., Hamady M., et al. Worlds within worlds: evolution of the vertebrate gut microbiota. Nat Rev Microbiol 6 (2008) 776-788
7. Schaefer T.M., Fahey J.V., Wright J.A., et al. Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist Poly(I:C). J Immunol 174 (2005) 992-1002
8. Aflatoonian R., Tuckerman E., Elliott S.L., et al. Menstrual cycle-dependent changes of Toll-like receptors in endometrium. Hum Reprod 22 (2007) 586-593
9. O'Neill L.A.J. Toll-like receptors in cancer. Oncogene 27 (2008) 158-160
10. Lanier L.L. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 8 (2008) 259-268
11. Waldhauer I., and Steinle A. NK cells and cancer immunosurveillance. Oncogene 27 (2008) 5932-5943
12. Moretta L., Bottino C., Pende D., et al. Surface NK receptors and their ligands on tumor cells. Semin Immunol 18 (2006) 151-158
13. Textor S., Durst M., Jansen L., et al. Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. Int J Cancer 123 (2008) 2343-2353
14. Arreygue-Garcia N.A., Daneri-Navarro A., del Toro-Arreola A., et al. Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions. BMC Cancer 8 (2008) 16
15. Albarran-Somoza B., Franco-Topete R., Delgado-Rizo V., et al. CEACAM1 in cervical cancer and precursor lesions: association with human papillomavirus infection. J Histochem Cytochem 54 (2006) 1393-1399
16. Jimenez F.R., Mendez C.R., Ojeda O.J., et al. High-risk human papillomavirus infection decreases the frequency of dendritic Langerhan's cells in the human female genital tract. Immunology 117 (2005) 220-228
17. García G., Pedroza A., Aguilar D., et al. Airways infection with virulent Mycobacterium tuberculosis delays the influx of dendritic cells and the expression of costimulatory molecules in mediastinal lymph nodes. Immunology 112 (2004) 661-668
18. Flores L.A., Meza P.S., Calderon A.J., et al. Network of dendritic cells within the muscular layer of the mouse intestine. PNAS 102 (2005) 19039-19044
19. Limon-Flores A.Y., Perez-Tapia M., Estrada-Garcia I., et al. Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. Int J Exp Pathol 86 (2005) 323-334
20. Stanley M.A. Immunochemistry and immunology of the cervix. In: Jordan J., Singer A., Jones III H.W., and Shafi M.I. (Eds). The Cervix. 2nd ed (2006), Blackwell Publishing, Oxford UK 49-61
21. Das K., Burday M., and Heller D.S. Pathology of inflammatory disease of the cervix. In: Jordan J., Singer A., Jones III H.W., and Shafi M.I. (Eds). The Cervix. 2nd ed (2006), Blackwell Publishing, Oxford UK 209-230
22. Friedell G.H., Hertig A.T., and Younge P.A. Carcinoma. Situ of the Uterine Cervix (1960), Charles C Thomas, Springfield
23. Underwood C.I. The ultrastructure of the local cellular reaction to neoplasia. In: Bourne E.G.H., and Denielli J.F. (Eds). International Review of Cytology (1974), Academic Press, New York
24. Marais D., Constant D., Allan B., et al. Cervical human papillomavirus (HPV) infection and HPV type 16 antibodies in South African women. J Clin Microbiol 46 (2008) 732-739
25. Lehtinen M., Pawlita M., Dillner M.J., et al. Evaluation of antibody response to human papillomavirus early proteins in woman whom cervical cancer developed 1-20 years later. Am J Obstet Gynecol 188 (2003) 49-55
26. Bard E., Riethmuller D., Meillet D., et al. High-risk papillomavirus infection is associated with altered antibody responses in genital tract: non-specific responses in HPV infection. Viral Immunol 17 (2004) 381-389
27. Neguye H.H., Broker T.R., Chow L.T., et al. Immune responses to human papillomavirus in genital tract of women with cervical cancer. Gynecol Oncol 96 (2005) 452-461
28. Nardelli-Haefliger D., Wirthner D., Schiller J., et al. Specific antibody levels at the cervix during menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Institute 95 (2003) 1128-1129
29. Marais D., Sampson C., Jeftha A., et al. More men than women make mucosal IgA antibodies to human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population. BMC Infect Dis 6 (2006) 95
30. Yeaman G.R., Guyre P.M., Fanger M.W., et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol 61 (1997) 427-435
31. White H. Proceeding Annual Meeting of the American Society for Reproductive Immunology; June 26; Knoxville, TN (1996), Blackwell Publishing, Oxford, UK
32. Frazer I.H. Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol 4 (2004) 46-54
33. Connor J., Ferrer K., John P., et al. Evaluation of Langerhans cells in the cervical epithelium of women with cervical intraepithelial neoplasia. Gynecol Oncol 75 (1999) 130-135
34. Hopfl R., Heim K., Christensen N., et al. Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 onco-protein E7. Lancet 356 (2000) 1985-1986
35. Kadish A., Timmins P., Wang Y., et al. Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide. Cancer Epidemiol Biomark Prevent 11 (2002) 483-488
36. Höhn H., Pilch H., Günzel S., et al. Human papillomavirus type 33 E7 peptides presented by HLA-DR*0402 to tumor-infiltrating T cells in cervical cancer. J Virol 74 (2000) 6632-6636
37. Daneri-Navarro A., Del Toro-Arreola S., Sanchez-Hernandez P.E., et al. Immunosuppressive activity of proteases in cervical carcinoma. Gynecol Oncol 98 (2005) 111-117
38. Daneri-Navarro A., Del Toro-Arreola S., Bravo-Cuellar A., et al. Proteolytic activity in extracts of invasive cervical carcinoma and precursor lesions. Biomed Pharmacother 49 (1995) 304-310
39. Borchers A., Braspenning J., Meijer J., et al. E7-specific cytotoxic T cell tolerante in HPV-transgenic mice. Arch Virol 144 (1999) 1539-1556
40. Reid S.W., McAdam S., Smith K.J., et al. Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J Exp Med 184 (1996) 2279-2286